Klin Onkol 2004; 17(2): 74-75.
Authors: Odrážka Karel, Petera Jiří2004-04-15:Hradec’s days 2004
Authors: Odrážka Karel, Petera Jiří2004-04-15:Hradec’s days 2004
Klin Onkol 2004; 17(2): 75-76.
Keywords: Czech Oncological Society CLS JEP
2004-04-15:Oncological associations
Keywords: Czech Oncological Society CLS JEP
2004-04-15:Oncological associations
Klin Onkol 2004; 17(Suppl 1): 4.
Authors: Dušek Ladislav, Žaloudík Jan2004-03-30:Editorial.
Authors: Dušek Ladislav, Žaloudík Jan2004-03-30:Editorial.
Klin Onkol 2004; 17(Suppl 1): 5-10.
Keywords: health technology assessment, oncology, quality of cancer care
Authors: Žaloudík Jan, Dušek Ladislav, Vyzula Rostislav2004-03-30:Concept of Health Technology Assessment (HTA) for Oncology
Keywords: health technology assessment, oncology, quality of cancer care
Authors: Žaloudík Jan, Dušek Ladislav, Vyzula Rostislav2004-03-30:Concept of Health Technology Assessment (HTA) for Oncology
Klin Onkol 2004; 17(Suppl 1): 11-26.
Keywords: oncology, health technology assessment, quaIíty of health care, efficacy of therapy, safety of therapy
Authors: Dušek Ladislav, Žaloudík Jan, Koptíková Jana, Mužík Jan, Abrahámová Jitka, Vyzula Rostislav, Vorlíček Jiří2004-03-30:Data Model for Health Technology Assessment in Oncology
Keywords: oncology, health technology assessment, quaIíty of health care, efficacy of therapy, safety of therapy
Authors: Dušek Ladislav, Žaloudík Jan, Koptíková Jana, Mužík Jan, Abrahámová Jitka, Vyzula Rostislav, Vorlíček Jiří2004-03-30:Data Model for Health Technology Assessment in Oncology
Klin Onkol 2004; 17(Suppl 1): 27-30.
Keywords: HTA, clinical decision support, clinical data management, healthcare quality
Authors: Bourek A., Forýtková L., Vlk D.2004-03-30:HTA: Elegant and Scientific Approach to Manage Uncertainty in Medicine ..
Keywords: HTA, clinical decision support, clinical data management, healthcare quality
Authors: Bourek A., Forýtková L., Vlk D.2004-03-30:HTA: Elegant and Scientific Approach to Manage Uncertainty in Medicine ..
Klin Onkol 2004; 17(Suppl 1): 31-36.
Keywords: HTA (Health Technology Assessment), DRG (Diagnosis Related Group), BEP (Brake Even Point), risk adjustment, healthcare quality
Authors: Suchý Miloš, Tůma P.2004-03-30:DRG Classification System and Helath Technology Assessment in Oncology
Keywords: HTA (Health Technology Assessment), DRG (Diagnosis Related Group), BEP (Brake Even Point), risk adjustment, healthcare quality
Authors: Suchý Miloš, Tůma P.2004-03-30:DRG Classification System and Helath Technology Assessment in Oncology
Klin Onkol 2004; 17(Suppl 1): 37-38.
Keywords: legal norms, clinical data processing, management of health care documentation, national registers, ethical aspects
Authors: Veselská Renata, Kuře Josef 2004-03-30:Legal and Ethical Aspects of Clinical Data Registration and Processing
Keywords: legal norms, clinical data processing, management of health care documentation, national registers, ethical aspects
Authors: Veselská Renata, Kuře Josef 2004-03-30:Legal and Ethical Aspects of Clinical Data Registration and Processing
Klin Onkol 2004; 17(Suppl 1): 39-44.
Keywords: cancer epidemiology, data registration, clinical registry
Authors: Dušek Ladislav, Abrahámová Jitka, Indrák Karel, Vyzula Rostislav, Žaloudík Jan, Vorlíček Jiří2004-03-30:Cancer Epidemiology Registration and its Role in Health Technology Assessment
Keywords: cancer epidemiology, data registration, clinical registry
Authors: Dušek Ladislav, Abrahámová Jitka, Indrák Karel, Vyzula Rostislav, Žaloudík Jan, Vorlíček Jiří2004-03-30:Cancer Epidemiology Registration and its Role in Health Technology Assessment
Klin Onkol 2004; 17(Suppl 1): 45-48.
Keywords: Pharmacoeconomy
Authors: Vlček Jiří2004-03-30:Pharmacoeconomical Analyses in Oncology
Keywords: Pharmacoeconomy
Authors: Vlček Jiří2004-03-30:Pharmacoeconomical Analyses in Oncology
Klin Onkol 2004; 17(Suppl 1): 49-50.
Keywords: Diagnostics in oncology, quality of health care
Authors: Abrahámová Jitka2004-03-30:Correct and Early Diagnostics as Necessary Prerequisite for Therapeutic Results in Oncology
Keywords: Diagnostics in oncology, quality of health care
Authors: Abrahámová Jitka2004-03-30:Correct and Early Diagnostics as Necessary Prerequisite for Therapeutic Results in Oncology
Klin Onkol 2004; 17(Suppl 1): 51-56.
Keywords: breast cancer, chronic myeloid leukemia, acute promyelocytic leukemia, ERBB2, bcr-abl, PML-RAR_, trastuzumab, imatinib mesylate, all-trans-retinoid acid
Authors: Hajdúch Marián, Jarošová Marie, Trojanec Radek, Indrák Karel, Bouchalová (Špačková) Kateřina, Papajík Tomáš, Cwiertka Karel2004-03-30:Cytogenetics and Molecular Biological Markers in Oncology and Hematooncology
Keywords: breast cancer, chronic myeloid leukemia, acute promyelocytic leukemia, ERBB2, bcr-abl, PML-RAR_, trastuzumab, imatinib mesylate, all-trans-retinoid acid
Authors: Hajdúch Marián, Jarošová Marie, Trojanec Radek, Indrák Karel, Bouchalová (Špačková) Kateřina, Papajík Tomáš, Cwiertka Karel2004-03-30:Cytogenetics and Molecular Biological Markers in Oncology and Hematooncology
Klin Onkol 2004; 17(Suppl 1): 57-60.
Keywords: oncological data, quality of oncological treatment, hospital information system, diagnostic and therapeutic standards
Authors: Kiss Igor, Skřičková Jana, Tomášek Jiří, Vyzula Rostislav, Žaloudík Jan, Vorlíček Jiří, Sedláčková Šárka2004-03-30:Diagnostics and Therapy of Cancer Disease in Parametric Data Records – Current Situation and Needs
Keywords: oncological data, quality of oncological treatment, hospital information system, diagnostic and therapeutic standards
Authors: Kiss Igor, Skřičková Jana, Tomášek Jiří, Vyzula Rostislav, Žaloudík Jan, Vorlíček Jiří, Sedláčková Šárka2004-03-30:Diagnostics and Therapy of Cancer Disease in Parametric Data Records – Current Situation and Needs
Klin Onkol 2004; 17(Suppl 1): 61-63.
Keywords: Health care, oncology, therapeutic effectiveness, economic expenses, farmacoeconomic model
Authors: Vyzula Rostislav, Novák Jiří, Koukalová H., Andres Pavel2004-03-30:Suitability of Clinical Data for the Efectiveness and Cost-Benefit Analyses in Oncology
Keywords: Health care, oncology, therapeutic effectiveness, economic expenses, farmacoeconomic model
Authors: Vyzula Rostislav, Novák Jiří, Koukalová H., Andres Pavel2004-03-30:Suitability of Clinical Data for the Efectiveness and Cost-Benefit Analyses in Oncology
Klin Onkol 2004; 17(Suppl 1): 64-67.
Keywords: individual treatment plan, parametric evaluation
Authors: Kiss Igor, Skřičková Jana, Vyzula Rostislav, Žaloudík Jan, Tomášek Jiří, Sedláčková Šárka, Vorlíček Jiří2004-03-30:Time-Related Data Records of Oncology Disease in Real Clinical Process – Case Study Model on Colorectal Carcinoma
Keywords: individual treatment plan, parametric evaluation
Authors: Kiss Igor, Skřičková Jana, Vyzula Rostislav, Žaloudík Jan, Tomášek Jiří, Sedláčková Šárka, Vorlíček Jiří2004-03-30:Time-Related Data Records of Oncology Disease in Real Clinical Process – Case Study Model on Colorectal Carcinoma
